Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
Clinical trial NCT04546841 · COMPLETED
Trial details
- NCT number
- NCT04546841
- Sponsor
- University Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2021-09-30
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.